Sharp Analysis. Verified Results. Expert Picks.
The Detroit Tigers are playing the long game, and sharps should be paying attention. The club committed $128 million to pitchers Justin Verlander and Framber Valdez this offseason, but here's the part that matters for bettors: $31 million of that total is deferred, with the final payments not arriving until 2039. That's not just a financial footnote. That's a front office signaling it has the flexibility to keep building, and it fundamentally changes how you should be pricing Detroit for the 2026 season and beyond.
Verlander signed a one-year, $13 million deal to return to Detroit, the franchise that originally drafted him. But of that $13 million, only $2 million lands in 2026. The remaining $11 million is deferred, paid out in $1.1 million installments every June 30 from 2030 through 2039. For a 43-year-old right-hander, this is a brilliant structure. The Tigers get a three-time Cy Young winner anchoring the back end of their rotation for a fraction of the immediate payroll hit.
Valdez's deal is the bigger piece. The left-hander signed a three-year, $115 million contract with a $38.3 million average annual value, which set a record for left-handed pitchers. His structure includes a $20 million signing bonus, but every dollar of that bonus is deferred in $2 million annual installments from 2030 through 2039. He collects $17.5 million in base salary this year and $37.5 million in 2027. He also holds a $35 million player option for 2028, plus a $40 million mutual option for 2029 with a $5 million buyout. Performance escalators add up to $2 million for a Cy Young Award, $1 million for ALCS MVP, and $2 million for World Series MVP.
| Pitcher | Total Value | 2026 Salary | Deferred | Final Payment |
|---|---|---|---|---|
| Justin Verlander | $13M / 1 yr | $2M | $11M | 2039 |
| Framber Valdez | $115M / 3 yr | $17.5M | $20M (bonus) | 2039 |
Here's the handicapping angle most casual bettors will miss completely. When a team defers money like this, it tells you the front office is managing present-day payroll to keep spending capacity open. The Tigers aren't just buying pitching for 2026. They're structuring their finances so they can continue to add pieces without bumping up against the competitive balance tax. That's the kind of organizational behavior that precedes sustained winning, not one-year flashes.
For context, the Dodgers owe a staggering $1.0945 billion in deferred payments to 10 players from 2028 through 2047. Detroit's $31 million deferral is modest by comparison, but the philosophy is identical: spend the money to win now, spread the financial pain across future years. The Dodgers have used this approach to win back-to-back World Series titles in 2024 and 2025. The Tigers are clearly taking notes.
Forget the deferred money for a moment and look at what the Tigers are actually trotting out to the mound in 2026. The projected rotation of Tarik Skubal, Framber Valdez, Justin Verlander, Jack Flaherty, and Casey Mize is legitimately one of the deepest in baseball. That's not hype. Two Cy Young winners, a two-time All-Star, a proven postseason arm, and a former first-round talent all in the same five-man group.
Skubal is the engine. His back-to-back AL Cy Young Awards, the first American League pitcher to go back-to-back since Pedro Martinez in 1999-2000, make him arguably the best pitcher in the sport. His 2025 numbers were absurd: 2.21 ERA, 241 strikeouts, 0.89 WHIP, and 6.5 bWAR across 195.1 innings. He didn't allow a run in 12 of his 31 starts, the most scoreless outings of at least six innings in Tigers history. Won his arbitration case and will earn $32 million in 2026. Worth every penny.
Valdez brings the durability the Tigers desperately needed. He topped 190 innings for the third time in four seasons in 2025, posting a 3.66 ERA with 187 strikeouts across 192 innings for Houston. He allowed two or fewer earned runs in 18 of his 31 starts. The 32-year-old is a workhorse who eats innings, keeps your bullpen fresh, and gives you a chance to win every fifth day. That consistency is gold for over/under totals.
Verlander is the wildcard that could pay off handsomely. His 2025 season with the Giants looked ugly on the surface at 4-11, but dig deeper and you find a pitcher who posted a 2.99 ERA after the All-Star break and closed the year with a 1.96 ERA over his last seven starts. Coming home to Detroit, where he spent the first 12 years of his career, adds a narrative edge. At 43, nobody's expecting him to be the ace. He just needs to give you six competitive innings every five days, and his second-half numbers suggest he can absolutely still do that.
The Tigers' win total is sitting at 85.5 at most books, with some shops posting 86.5. Detroit went 87-75 in 2025, made the playoffs, beat the Guardians in the AL Wild Card Series, and fell to the Mariners in the ALDS. The rotation is objectively better heading into 2026 with Valdez replacing a lesser arm and Verlander providing experienced depth.
The case for the over: this rotation has the potential to suppress runs at an elite level, and pitching is the most stable predictor of team wins from year to year. Skubal alone is worth four to five wins above a replacement-level starter. Valdez adds another three to four. If Verlander, Flaherty, and Mize each contribute two to three wins, that is a rotation capable of carrying a roster through a 162-game grind.
The case against: Detroit's offense remains a question mark, and the Tigers collapsed down the stretch in 2025, going 7-17 in September after being as many as 25 games over .500 on July 8. That kind of late-season fade is a red flag. But the pitching additions directly address the problem. The second-half collapse was partly a function of rotation depth wearing thin. That shouldn't happen with five legitimate starters in the fold.
The Tigers are currently the AL Central favorites at +155, with the Guardians at +300 and the Twins buried at +900. Cleveland won the division in 2025 with an 88-74 record, finishing just one game ahead of Detroit, but the market has clearly shifted its projection based on Detroit's pitching upgrades.
This is where the deferred payment structure becomes a real handicapping factor. The Tigers have committed $128 million to two pitchers while keeping their immediate payroll obligation relatively lean. That kind of financial engineering gives them the ability to swing a mid-season trade for a bat if the offense is lagging, or to add bullpen reinforcement for a playoff push. Cleveland, by contrast, tends to operate with tighter financial constraints.
At +155 to win the division, Detroit is priced as a team that should win the AL Central roughly 39% of the time. Given the rotation advantage and the front office's clear commitment to spending, that looks close to fair value. The sharper play might be to wait for the regular season to unfold and target Detroit's division odds if they stumble early and the price gets longer. But at this number, there is nothing to fade.
The deferred payment story is not just a financial curiosity. It is a window into how the Tigers' front office is thinking about competitive windows, payroll management, and roster construction. They are building a pitching staff that can carry a team deep into October while maintaining the financial flexibility to address weaknesses on the fly. That is the playbook of a franchise that expects to be competitive not just in 2026, but for multiple years.
For bettors, the takeaway is straightforward: respect the process. A team deferring $31 million over the next 13 years to secure elite pitching right now is a team that believes its championship window is open. The rotation of Skubal, Valdez, Verlander, Flaherty, and Mize has the depth to win a division and the ceiling to win a pennant. Keep the Tigers on your radar for win totals, division futures, and AL pennant odds. This is a front office that is spending like a contender, and the betting market is starting to price them accordingly.